Microsart® Validation Standard Mycoplasma orale, 432,50 €

Cookiename	Beispielinhalt	Ablaufzeit
_ga_*	deleted	730 Tage
_ga	GA1.1.8643343795.1726666186	730 Tage

Chapter 2.6.7 'Mycoplasmas' of the European Pharmacopoeia requires the validation of robustness and sensitivity considering the sample matrix. Furthermore, it must be shown that the method to be validated generates comparable or better results than the classical culture method. Since the majority of cell culture laboratories are prohibited from culturing mycoplasmas in their own laboratories, assay validation at the CFU level is often not possible in-house. Microsart® Validation Standards are non-infectious and therefore safe to handle without risking mycoplasma contamination of the cell culture laboratory. They were titrated to a concentration of 10 CFU/ml, which is the sensitivity limit for NAT-based methods to replace the classical culture method. The mycoplasmas were harvested in the early logarithmic phase of growth to avoid an atypically high ratio of dead mycoplasmas and consequently a high GU:CFU ratio. All strains were obtained from the National Collection of Type Cultures (NCTC) Great Britain. Microsart Validation Standard Mycopl, Microsart® Validation Standard Mycoplasm

Product safety information

Manufacturer information:

Sartorius

, ,

There are no reviews yet.